Allarity Therapeutics (ALLR) executive compensation, 2026 proxy

Thomas H. Jensen, Chief Executive Officer, was paid $1.5M in 2025, up 84% from $791,600 the year before.

Filed
April 30, 2026
Annual meeting
June 26, 2026
Pay year
2025
Named executives
5
CEO total pay
$1.5M+84% vs prior year
CEO pay in equity
27%$400,701 in awards
CEO 2025 Total Pay
$1,458,950Up from $791,600 in 2024
CEO Salary
$647,383Includes management service fees
CEO Bonus
$355,500Earned in 2025 and paid in 2026
CEO Stock Awards
$400,701Grant date fair value

How Jensen was paid

$1.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary44%Bonus24%Stock awards27%All other compensation4%

Named executive officers

ExecutiveTotal
Thomas H. JensenChief Executive Officer$1,458,950
Jeffrey S. ErvinChief Financial Officer$158,531
Jeremy R. GraffPresident and Chief Development Officer$908,818
Steen KnudsenChief Scientific Officer$236,802
Alexander EpshinskyFormer Chief Financial Officer$383,546

What changed and why

  • $1.5MThomas H. Jensen received total compensation of $1,458,950 for fiscal year 2025, an increase from $791,600 in 2024.
  • $647KThe CEO base salary and fees component totaled $647,383, supplemented by $355,500 in bonus compensation.
  • $401KStock awards granted to the CEO amounted to $400,701 in 2025.
  • $55,366All other compensation for the CEO reached $55,366 during the year.
  • Jeffrey S. Ervin became Chief Financial Officer on a full-time basis in December 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.